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Abstract : Purpose To evaluate the perioperative symptoms of gastric cancer patients undergoing gastrectomy 
using the Edmonton Symptom Assessment System Revised Japanese version (ESAS-r-J), which is a nine-item 
visual analogue scale to rate patient symptoms. Methods Between February 2015 and March 2017, 246 patients 
completed the ESAS-r-J before and after gastrectomy. We evaluated the changes in the prevalence and score of 
each ESAS-r-J item before and after gastrectomy. In addition, we compared them after gastrectomy between 
patients who underwent the different approaches. Results Before gastrectomy, anxiety and well-being were the 
most prevalent items (80%), followed by depression (45%). After gastrectomy, well-being was the most prevalent 
item (87%), followed by pain (68%). The prevalence of anxiety decreased from 80% to 59% (P = 0.002). The depres-
sion and anxiety scores decreased from 1.6 to 1.1 (P < 0.001) and from 2.6 to 1.7 (P = 0.002), respectively. The total 
score was higher in patients who underwent open surgery than in patients who underwent laparoscopic surgery 
(16.9 vs 12.9 ; P = 0.031). Conclusions After gastrectomy, psychological symptoms such as depression and anxiety 
improved despite more physical complaints than before gastrectomy. The laparoscopy was less invasive. It is 
very important to take care of psychological aspects before gastrectomy. J. Med. Invest. 68 : 90-95, February, 2021
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INTRODUCTION
 
Although the long-term survival of patients with gastric 
cancer has improved because of early diagnosis and advances 
in multimodality management, patients sometimes suffer from 
various symptoms, including early satiety, loss of appetite, 
heartburn, dysphagia, nausea, and vomiting. When evaluating 
treatment for cancer, health-related quality of life (QOL) has 
been acknowledged to be an important endpoint in addition to 
oncologic outcomes and safety issues (1, 2).
Korenaga et al. (3) developed their own sets of questions to 
evaluate the QOL of postgastrectomy patients. Recently, generic 
QOL instruments designed in the form of questionnaires have 
been developed. These include the Functional Assessment of 
Cancer Therapy-General (FACT-G) by the Functional Assess-
ment of Chronic Illness Therapy QoL group, the European 
Organization for Research and Treatment of Cancer (EORTC) 
Quality of Life Questionnaire Core 30 (QLQ-C30) by the EORTC 
QoL group (4), and the site-specific module for gastric cancer 
(EORTC QLQ-STO22) (5) ; the validity of these questionnaires 
have been reported (6).
The Edmonton Symptom Assessment System Revised Japanese 
version (ESAS-r-J) is a self-report symptom measurement tool 
that includes six items related to physical symptoms and three 
related to psychologic symptoms such as depression, anxiety, 
and well-being (7). A series of validation studies complemented 
the rapid clinical implementation of the ESAS, providing further 
evidence for its psychometric properties and clinical utility (8). 
There are few studies examining the QOL of patients with gas-
tric cancer in the perioperative period using the ESAS-r-J.
To our knowledge, this is the first study evaluating the periop-




Between February 2015 and March 2017, a total of 246 pa-
tients with gastric cancer underwent total gastrectomy (TG), 
proximal gastrectomy (PG) or distal gastrectomy (DG) and 
completed the ESAS-r-J before and after (before discharge) 
gastrectomy. 
Usually, we explained the clinical stages and the type of 
operation to the patients in the outpatient department and the 
preoperative assessment using the ESAS-r-J was performed the 
day before gastrectomy. The postoperative assessment using the 
ESAS-r-J was performed the day before discharge, at which time 
the pathological stage had been already informed to the patients.
This study was approved by the Ethics Review Board of Ogaki 
Municipal Hospital. The subject provided informed consent, and 
patient anonymity was preserved. We retrospectively reviewed 
the medical records and evaluated the following : (1) patient 
characteristics ; (2) surgical outcomes and histological find-
ings ; (3) changes in the prevalence and score of each ESAS-r-J 
item before and after gastrectomy (The prevalence was consid-
ered to be present if the score for the symptom was rated as > 0) ; 
and (4) differences in the prevalence and score of each ESAS-r-J 
item after gastrectomy between patients who underwent TG 
or PG procedures and those who underwent DG, patients who 
underwent a laparoscopic approach and those who underwent an 
open approach, and patients with morbidity and those without 
morbidity.
Postoperative morbidities were evaluated according to the 
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Clavien–Dindo classification (9), and grade II or higher was 
considered significant.
MEASURES
The ESAS (10) is a self-report symptom assessment mea-
sure consisting of nine common symptom-related items for 
advanced cancer : pain, tiredness, nausea, depression, anxiety, 
drowsiness, appetite, well-being, and shortness of breath, with 
the option of adding a tenth patient-specific symptom. Patients 
rated the intensity of each of these symptoms. Each symptom 
rating is interpreted independently, although it is also possible 
to calculate a total symptom distress score. The ESAS-r (11) is a 
modified version of the ESAS. The time frame for the symptom 
ratings is specified as ‘now’. Patients rated the intensity of each 
symptom at a point in time (current) using an 11-point numer-
ical rating scale, ranging from 0 (symptom absent or best) to 
10 (worst possible) (Fig. 1). The ESAS-r-J was translated into 
Japanese by Yokomichi et al. (7).
INTERVENTIONS
Patients were treated according to our institutional practices 
for patients with gastric cancer (12, 13). Briefly, patients under-
went staging investigations, including computed tomography, 
endoscopic ultrasonography, and / or laparoscopy. The surgical 
procedures were classified as follows : distal gastrectomy (DG) 
if the procedure included the distal stomach and pylorus but not 
the esophagogastric junction ; proximal gastrectomy (PG) if the 
procedure included the proximal stomach and esophagogastric 
junction but not the distal stomach ; and total gastrectomy (TG) 
if the entire stomach was resected. Patients who underwent 
wedge resections were not included in this study. Reconstruction 
was performed with Billroth I or Billroth II after DG, jejunal 
interposition after PG (12), and Roux-en-Y after TG. An open 
approach was performed for patients over 81 years old, with 
organ dysfunction (i.e., cardiovascular or respiratory dysfunc-
tion or coagulation), who had previous upper abdominal surgery, 
or who had low-performance status. Preoperatively, if the pa-
tients preferred different type of the procedure and the approach, 
we had a thorough discussion with the patients and ultimately 
respected the patient’s hopes.
STATISTICAL ANALYSIS
All statistical analyses were performed with EZR, which is a 
graphical user interface for R (The R Foundation for Statistical 
Computing, version 2.13.0) (14). The McNemar test was used to 
compare the prevalence of the nine items, and a paired t-test 
was used to compare the nine items and total scores before and 
after gastrectomy. In comparison with the prevalence and scores 
of each category after gastrectomy, Fisher’s exact test was used 
to compare categorical variables, and the Mann–Whitney U-test 
was used to compare continuous variables. A value of p < 0.05 
was considered statistically significant.
RESULTS
In this study, 246 patients were enrolled. Among these pa-
tients, eight patients (3.3%) required blood transfusions due 
to anemia and two patients (0.8%) required total parenteral 
nutrition due to gastrointestinal obstruction as preoperative 
management. There were no patients required analgesics for 
cancer pain.
The clinical characteristics and surgical outcomes and his-
tological findings of the patients are summarized in Tables 1 
and 2, respectively. Laparoscopic surgery was performed for 133 
patients (54%). The most frequent procedure was DG (57%), fol-
lowed by TG (39%), and PG (3.7%). The mean operation time was 
165 min (range, 60–326), and the mean estimated blood loss was 
Fig 1.　ESAS-r (Edmonton Symptom Assessment System-revised).
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133 mL (range, 1–1250). The overall incidence of postoperative 
complications (CD ≧ grade II) was 14%. There was no postop-
erative mortality. The detail of postoperative complications are 
demonstrated in Table 3. Among Leakage (n = 7), anastomotic 
leakage at the esophagojejunostomy site occurred in 3 patients, 
duodenal stump leakage in 2 patients, jejunum stump leakage 
in 1 patient, and 1 patient developed pancreatic fistula followed 
by secondary anastomotic leakage at the gastroduodenostomy 
site. Reoperation was required in 1 patient. The causes of reop-
eration was anastomotic stenosis at the gastrojejunostomy site. 
25 patients (10%) were required a temporary fast to cure the 
complication.
The prevalence of each ESAS-r-J item before and after gas-
trectomy is shown in Table 4. Before gastrectomy, anxiety and 
well-being were the most prevalent items (80%), followed by 
depression (45%). After gastrectomy, well-being was the most 
prevalent item (87%), followed by pain (68%). The prevalence 
of anxiety decreased from 80% before gastrectomy to 59% 
after gastrectomy (P = 0.002). Depression showed a tendency 
to decrease after gastrectomy without statistically significant 
differences. Other than these items, the other items increased 
significantly after gastrectomy. Fig. 2 shows the changes in the 
ESAS-r-J item scores before and after gastrectomy. The anxiety 
and depression scores decreased from 2.6 to 1.7 (P = 0.002) and 
from 1.6 to 1.1 (P < 0.001), respectively. Except for well-being, 
the scores of the other items and total scores increased signifi-
cantly after gastrectomy. Particularly, large fluctuations were 
observed in pain and lack of appetite. Table 5 shows a compar-
ison of the prevalence and score of each ESAS-r-J item after 
gastrectomy. The depression score was higher in patients who 
underwent TG or PG than in patients who underwent DG (1.5 
vs 0.9 ; P = 0.046). The total score was higher in patients who un-
derwent the open surgery than those who underwent laparoscop-
ic surgery (16.9 vs 12.9 ; P = 0.031). The patients with morbidity 
had more shortness of breath than those without morbidity (47% 
vs 30% ; P = 0.049). There were no significant differences in the 
prevalence and score of each ESAS-r-J item between groups of 
patients of different sexes and tumor stages (data not shown).
 
Table 1.　Clinical Characteristics
Number of patients 246
Age (years), mean (range) 68.9 (34-81)
Male 175 (71%)
BMI (kg / m2), mean (range) 23.4 (14.1-38.3)
Comorbidities 133 (54%)
Hypertension 76 (31%)
Diabetes mellitus 36 (15%)
Ischemic heart disease 15 (6.1%)
COPD 10 (4.0%)
Cerebral vascular disease 20 (8.1%)
Anti-coagulant therapy 14 (5.7%)
BMI, body mass index ; COPD, chronic obstructive pulmonary 
disease.
Table 2.　Surgical Outcomes and Histological Findings (UICC)





Operation time (min), mean (range) 165 (60-326)
Blood loss (mL), mean (range) 133 (1-1250)
Morbidity (≧Grade II) 34 (14%)
Mortality 0
Postoperative hospital stay (days)
mean (range) 16.4 (9-99)
Stage*
I (IA / IB) 146 (126 / 20)
II (IIA / IIB) 38 (26 / 12)
III (IIIA / IIIB / IIIC) 52 (16 / 19 / 17)
IV 10
*Data are shown as number of patients.
Grade is according to the Clavien–Dindo classification.
UICC, UICC TNM classification, 7th edition.
Table 3.　Postoperative Complications
Any complication (≧Grade II) 34 (14%)
Pancreatic fistula 11 (4.5%)
Leakage 7 (2.8%)
Pneumoniae 6 (2.4%)
Anastomotic stenosis 4 (1.6%)
Bowel obstruction 3 (1.2%)
Anastomotic bleeding 2 (0.8%)
Abdominal abscess 2 (0.8%)
Abdominal bleeding 1 (0.4%)
Requiring reoperation 1 (0.4%)
Grade is according to the Clavien–Dindo classification 







Pain 24 68 < 0.001
Tiredness 26 49 < 0.001
Drowsiness 35 53 < 0.001
Nausea 8.5 24 < 0.001
Lack of Appetite 21 57 < 0.001
Shortness of Breath 16 32 < 0.001
Depression 45 42 0.50 
Anxiety 80 59 0.002 
Well-being 80 87 0.041 
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DISCUSSION
Cancer patients may have poor QOL due to the disease itself 
before surgery. After surgery, the patients may still suffer from 
poor QOL due to oncologic problems and the consequences of 
surgery. In the current study, the perioperative symptoms of 
gastrectomy were evaluated using the ESAS-r-J. After gastrec-
tomy, psychological symptoms, such as depression and anxiety, 
improved despite more physical complaints than before gastrec-
tomy. The recognition of this result is an important metric for the 
delivery of optimal quality of care.
In fact, health-related QOL should include physical, social and 
psychological aspects. Several studies have investigated the post-
surgical QOL of patients with gastric cancer. Among these stud-
ies, the EORTC QLQ-C30 and QLQ-STO22 questionnaires have 
been well validated. The EORTC QLQ-C30 is a cancer-specific 
30-question instrument. The EORTC QLQ-STO22 takes into 
consideration 22 additional items relating to gastric cancer. The 
average time required to complete the EORTC QLQ-C30 was 
approximately 11 minutes (4). The ESAS-r was first described 
in a group of palliative care patients in a hospice setting (10). 
Because of its brevity and ease of administration, the ESAS-r 
has received much interest as a bedside clinical instrument. 
In a review of QOL tools for patients with cancer, the proposed 
criteria for an ideal instrument included the following character-
istics : simple to read and follow, quick and easy to complete and 
analyze, and based on a categorical or visual analogue scale. The 
average time required to complete the ESAS-r was considered to 
be shorter than that to complete the EORTC QLQ-C30 and the 
EORTC QLQ-STO22 because there are only nine items. Chang 
VT et al. (15) validated the ESAS-r in 240 patients with cancer 
and reported that the ESAS-r may be a valid instrument to use 
in a medical oncology population and that the ESAS-r distress 
score may predominantly reflect physical well-being.
In this study, the prevalence and scores of the psychological 
symptoms, such as depression and anxiety, in contrast those 
of the other items, were highest before surgery and steadily 
improved after surgery. Since the preoperative ESAS-r-J was 
taken after being diagnosed with gastric cancer, the psycholog-
ical symptoms from being diagnosed with cancer could have 
affected the preoperative prevalence and score, and the relief 
from the disease burden after surgery perhaps improved the 
symptoms after surgery. These results are consistent with those 
from the study (n = 36) by Schmidt-Matthiesen A et al. who used 
the Eypasch (self-assessment) (16) and those from the study 
(n = 272) by Kong H et al. who used the EORTC QLQ-C30 (17).
The prevalence and scores of the other items such as pain, 
tiredness, drowsiness, nausea, lack of appetite, and shortness 
of breath increased significantly after surgery. Particularly 
large fluctuations were observed for pain and lack of appetite. 
Kobayashi et al. (18) and Kong H et al. (17) reported that pain 
did not show any statistically significant patterns in their study. 
This may be because the questionnaire was taken at 1 month 
and 3 months after surgery, respectively. We expected the prev-
alence and score of pain to rapidly recover afterwards. The lack 
of appetite can be explained as one of the detrimental adverse ef-
fects of gastrectomy. The other items, other than pain and lack of 
appetite, are physical symptoms, and the cause of these patterns 
can be explained as one of the detrimental adverse effects of 
surgery. Kong H et al. (17) reported that many of these symptoms 
were worse at 3 months after surgery and improved or did not 
fully recover 1 year postoperative. Therefore, further follow-ups 
are necessary to confirm if these symptoms will recover.
Moreover, to compare the outcomes of different surgical pro-
cedures (DG vs TG or PG), approaches (laparoscopic vs open), 
and morbidity status (with vs without), we analyzed subgroup 
of patients in terms of QOL. Although the extent to which the 
different types of resection or approach affected QOL remains 
poorly defined, it has been well documented that DG is superior 
to TG (3, 19, 20) and that laparoscopic surgery shows an advan-
tage over open surgery for a few weeks after surgery (21). In this 
study, there were no differences between the different surgical 
procedure (DG vs TG, PG) groups, except for the depression 
score. A limitation of this study is that the time interval from the 
date of surgery to the first time the questionnaire was completed 
was too short. Therefore, further follow-ups are necessary to 
confirm if there were differences. The total symptom score was 
lower in the laparoscopy group than in the open group. This result 
Fig 2.　The mean scores of all patients who underwent gastrectomy for gastric cancer were calculated before and after gastrectomy. 
The mean scores are presented with s.e. (bars).
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A
ESAS-r Item





DG (n = 140) TG, PG (n = 106) DG  (n = 140) TG, PG (n = 106)
Pain 73 61 0.072 1.5 (1.5) 1.4 (1.7) 0.18 
Tiredness 50 48 0.80 1.2 (1.6) 1.3 (1.9) 0.98 
Drowsiness 50 57 0.37 1.2 (1.6) 1.4 (1.7) 0.27 
Nausea 23 26 0.55 0.5 (1.0) 0.6 (1.3) 0.46 
Lack of Appetite 56 59 0.80 1.7 (2.0) 2.1 (2.5) 0.42 
Shortness of Breath 31 33 0.89 0.8 (1.5) 0.8 (1.4) 0.84 
Depression 39 47 0.19 0.9 (1.5) 1.5 (2.1) 0.046 
Anxiety 58 60 0.70 1.5 (1.8) 2.0 (2.3) 0.18 
Well-being 85 89 0.45 2.9 (1.9) 3.3 (2.1) 0.19 
Total - - - 13.7 (10.2) 16.0 (14.0) 0.39 
B
ESAS-r Item





Laparo (n = 133) Open (n = 113) Laparo (n = 133) Open (n = 113)
Pain 68 67 0.89 1.3 (1.3) 1.6 (1.8) 0.37 
Tiredness 50 49 0.90 1.1 (1.5) 1.4 (1.9) 0.65 
Drowsiness 52 54 0.80 1.1 (1.4) 1.5 (2.0) 0.24 
Nausea 20 29 0.14 0.4 (0.8) 0.8 (1.4) 0.051 
Lack of Appetite 57 58 1.00 1.8 (2.0) 2.0 (2.5) 0.74 
Shortness of Breath 29 35 0.34 0.6 (1.2) 1.0 (1.7) 0.18 
Depression 38 47 0.20 0.9 (1.4) 1.4 (2.1) 0.07 
Anxiety 57 61 0.60 1.5 (1.8) 1.9 (2.3) 0.17 
Well-being 86 88 0.71 2.9 (1.9) 3.3 (2.2) 0.15 
Total - - - 12.9 (9.6) 16.9 (14.1) 0.031 
Table 5.　Prevalence and mean scores of the symptoms after gastrectomy 
DG, Distal gastrectomy ; TG, Total gastrectomy ; PG, Proximal gastrectomy
    (A)  DG vs TG or PG
    (B)  Laparoscopic approach vs open approach
    (C)  with morbidity vs without morbidity
C
ESAS-r Item





Yes (n = 34) No (n = 212) Yes (n = 34) No (n = 212)
Pain 56 70 0.11 1.3 (1.9) 1.5 (1.5) 0.16 
Tiredness 47 50 0.85 1.6 (2.2) 1.2 (1.6) 0.73 
Drowsiness 50 53 0.85 1.3 (1.7) 1.3 (1.7) 0.99 
Nausea 32 23 0.28 0.6 (1.1) 0.5 (1.2) 0.32 
Lack of Appetite 62 57 0.71 2.6 (2.9) 1.8 (2.1) 0.23 
Shortness of Breath 47 30 0.049 1.1 (1.7) 0.76 (1.4) 0.10 
Depression 41 43 1.00 1.4 (2.4) 1.1 (1.7) 0.87 
Anxiety 53 60 0.46 2.0 (2.7) 1.6 (1.9) 0.92 
Well-being 94 85 0.18 3.7 (2.4) 3.0 (2.0) 0.12 
Total - - - 17.4 (15.6) 14.3 (11.3) 0.45 
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suggested that the laparoscopy was less invasive, which is in line 
with the findings of a previous study (21, 22). The prevalence of 
shortness of breath was higher in patients with morbidity than 
in those without morbidity. This may have resulted because 
some patients with complications may not have been completely 
cured before being discharged. The details are unknown. 
The most important result in this study is that many patients 
with gastric cancer have the psychological symptoms, such as 
depression and anxiety before gastrectomy. Nowadays, the Pal-
liative Care Certified Nurse is present in the informed consent 
before gastrectomy and takes care of psychological aspects.
The current study has several limitations. First, there were 
not enough cases for each type of surgery. We did not separate 
each case by the type of surgery to review the overall picture. An-
other limitation is that marked differences in background (e.g., 
sex, age, incidence of combined resection) were observed between 
patients who underwent different procedures and approaches. 
Therefore, further studies comparing the type of surgery will be 
necessary.
In conclusions, after gastrectomy, psychological symptoms, 
such as depression and anxiety, improved despite more physical 
complaints than before gastrectomy. However, it is very import-
ant to take care of psychological aspects before gastrectomy. 
Also, further follow-ups would be helpful in determining which 
scales are permanently affected and which are need time to 
recover. 
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